InvestorsHub Logo
Followers 41
Posts 1440
Boards Moderated 0
Alias Born 04/05/2009

Re: 123tom post# 885

Tuesday, 04/22/2014 12:04:25 PM

Tuesday, April 22, 2014 12:04:25 PM

Post# of 3806
I think you are overanalyzing things and thus missing the obvious. There is news in the pipeline. The redchip thing is tomorrow then soon after that should be some announcement about recruitment in the cohort and then the shareholder meeting. That's about 3 things in the next 3 weeks. The inflection point will be in July/August but there are any number of surprises in between like the EACRI guys in Portland. Possibly news presented at a conference. Maybe some more intellectual property. The biotechs might bounce and come back too.

Why is the market cap of GALT so low when compared to ICPT? GALT's drug is better and could treat a much larger patient population. The market cap should be $5 bil +. GALT could be in a phase II by the end of the year if the second cohort is a home run. That would put them on par with ICPT in the development process. GALT is way undervalued here.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News